Références
citées
[1] Cartron, E., Fouret, G., Carbonneau, M-A., Lauret,
C., Michel, F., Monnier, L., Descomps, B., Léger,
C.L. (2003) Free Rad. Res., sous presse.
[2] Keys, A. (1970) “Coronary heart disease
in seven countries”, Circulation 41, (Suppl.1).
[3] Keys, A., Menotti, A., Karvonen, M.J., Aravanis,
C., Blackburn, H., Buzina, R., Djordjevic, B.S., Dontas,
S., Fidanza, F., Keys,M.H. et al. (1986), The diet
and 15-year death rate in the seven countries study,
Am. J. Epidemiol. 124, 903-915.
[4] Richard J.-L. Les facteurs de risque coronarien.
Le paradoxe français. Arch. Mal. Cœur,
n° spécial avril, 1987 : 17-21.
[5] Barefoot, J.C, Gronbaek, M., Feaganes, J.-R.,
McPherson, R.S., Williams, R.B., Siegler, I.C. (2002),
Alcoholic beverage preference, diet, and health habits
in the UNC Alumni Heart Study, Am. J. Clin. Nutr.
76, 466-472.
[6] Tjonneland, A., Gronbaek, M., Stripp, C., Overvad,
K. (1999), Wine intake and diet in a random sample
of 48 763 Danish men and women, Am. J. Clin. Nutr.
69, 49-54.
[7] Carbonneau, M-A., Léger, C.L., Monnier,
L., Bonnet, C., Michel, F., Fouret, G., Dedieu, F.,
Descomps, B. (1997). Supplementation with wine phenolic
compounds increases the antioxidant capacity of plasma
and vitamin E of low-density lipoprotein without changing
the lipoprotein Cu2 +-oxidizability : possible explanation
by phenolic location, Eur. J. Clin. Nutr. 51, 682-690.
[8] Rice-Evans, C.A. (2000), Measurement of total
antioxidant activity as a marker of antioxidant status
in vivo : procedures and limitations, Free Rad. Res.
33, S59-S66. |
|
[9] Léger, C.L., Carbonneau, M-A., Descomps,
B (2000), Consommation de vin et prévention
contre les maladies cardiovasculaires. In “Alimentation
Méditerranéenne et Santé, actualités
et perspectives”, John Libbey Eurotext éditeur,
Paris, pp. 81-97.
[10] Van der Gaag, M.S., Van den Berg, R., Van den
Berg, H., Schaafsma, G., Hendriks, H.F.J. (2000),
Moderate consumption of beer, red wine and spirits
has counteracting effects on plasma antioxidants
in middle-aged men, Eur. J. Clin. Nutr. 54, 586-591.
[11] Smith, SC, Greenland, P., Grundy, S.M. (2000),
Prevention conference V : beyond secondary prevention
: identifying the high-risk patient for primary
prevention. Executive summary. Circulation, 101,
111-116.
[12] Luc, G., Bard, J.-M., Ferrieres, J., Evans,
A., Amouyel, P., Arveiler, D., Fruchart, J.-C.,
Ducimetiere, P (2002), Value of HDL cholesterol,
apolipoprotein A-I, lipoprotein A-I, and lipoprotein
A-I/A-II in prediction of coronary heart disease
: the PRIME Study. Prospective Epidemiological Study
of Myocardial Infarction. Arterioscler Thromb Vasc
Biol. 22, 1155-1161.
[13] Rimm, E.B., Williams, P., Fosher, K., Criqui,
M., Stampfer, M.J. (1999) Moderate alcohol intake
and lower risk of coronary heart disease : meta-analysis
of effects on lipids and haemostatic factors. BMJ
319, 1523-1528.
[14] Rosenkranz, S., Knirel, D., Dietrich, H., Flesch,
M., Erdmann, E., Bohm, M. (2002), Inhibition of
the PDGF receptor by red wine flavonoids provides
a molecular explanation for the "French paradox",
FASEB J. 16, 1958-1960.
[15] Xu, R., Yokoyama, W.H., Irving, D., Rein, D.,
Walzem, R.L., German, J.-B. (1998), Effect of dietary
catechin and vitamin E on aortic fatty streak accumulation
in hypercholesterolemic hamsters, Atherosclerosis
137, 29-36. |
Guide des vins "Vins et Santé"